{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:22:04Z","timestamp":1762521724491},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002953","name":"Eisai Co. Ltd.","doi-asserted-by":"publisher","award":["H24-007"],"award-info":[{"award-number":["H24-007"]}],"id":[{"id":"10.13039\/501100002953","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health, Labour and Welfare Ministry","award":["H26-007"],"award-info":[{"award-number":["H26-007"]}]}],"content-domain":{"domain":["jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jdermsci.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,10,25]],"date-time":"2014-10-25T11:18:41Z","timestamp":1414235921000},"page":"206-213","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP"],"prefix":"10.1016","volume":"76","author":[{"given":"Tsugunobu","family":"Andoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kuraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2014.10.005_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0625.2007.00664.x","article-title":"Neurophysiological and neurochemical basis of modern pruritus treatment","volume":"17","author":"St\u00e4nder","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1367-5931(99)80068-4","article-title":"Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents","volume":"3","author":"Doherty","year":"1999","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0015","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1211\/jpp.57.12.0011","article-title":"The phosphodiesterase 4 inhibitor AWD 12-281 is active in a new guinea-pig model of allergic skin inflammation predictive of human skin penetration and suppresses both Th1 and Th2 cytokines in mice","volume":"57","author":"Hoppmann","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/187152807780077318","article-title":"Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis","volume":"6","author":"B\u00e4umer","year":"2007","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.intimp.2008.09.011","article-title":"Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models","volume":"9","author":"Harada","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0030","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.bmcl.2009.03.007","article-title":"Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis","volume":"19","author":"Akama","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12297888","article-title":"Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis","volume":"107","author":"Hanifin","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/jpet.113.205542","article-title":"Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model","volume":"346","author":"Ishii","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1346-8138.12534","article-title":"Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle-controlled, multicenter clinical trial","volume":"41","author":"Furue","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/exd.12377","article-title":"Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis","volume":"23","author":"Andoh","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0055","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1254\/jphs.08332FP","article-title":"Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itch-associated response in mice with atopy-like dermatitis","volume":"109","author":"Tsujii","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0060","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0065","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.intimp.2009.08.006","article-title":"Induction of leukotriene B4 and prostaglandin E2 release from keratinocytes by protease-activated receptor-2-activating peptide in ICR mice","volume":"9","author":"Zhu","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0070","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1600-0625.2011.01346.x","article-title":"Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions","volume":"20","author":"Andoh","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)00780-B","article-title":"Scratching behavior induced by pruritogenic but not algesiogenic agents in mice","volume":"275","author":"Kuraishi","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.0022-202X.2004.22704.x","article-title":"Intradermal nociceptin elicits itch-associated responses through leukotriene B4 in mice","volume":"123","author":"Andoh","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0085","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/mol.109.062018","article-title":"PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology","volume":"77","author":"McCoy","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0090","doi-asserted-by":"crossref","first-page":"e66743","DOI":"10.1371\/journal.pone.0066743","article-title":"Distinctive G protein-dependent signaling by protease-activated receptor 2 (PAR2) in smooth muscle: Feedback inhibition of RhoA by cAMP-independent PKA","volume":"8","author":"Sriwai","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(98)00440-3","article-title":"Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice","volume":"353","author":"Andoh","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0100","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1046\/j.0022-202x.2001.01585.x","article-title":"Involvement of leukotriene B4 in substance P-induced itch-associated response in mice","volume":"117","author":"Andoh","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0105","doi-asserted-by":"crossref","first-page":"41512","DOI":"10.1074\/jbc.M312568200","article-title":"Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523","volume":"279","author":"Luo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0110","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.4049\/jimmunol.181.5.3515","article-title":"Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production","volume":"181","author":"Ye","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0115","doi-asserted-by":"crossref","first-page":"34444","DOI":"10.1074\/jbc.M109.048942","article-title":"Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization","volume":"284","author":"Ricks","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0120","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/sj.jid.5700169","article-title":"Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells","volume":"126","author":"Moormann","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.intimp.2004.03.001","article-title":"Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes","volume":"4","author":"Barreto","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1254\/jphs.08200SC","article-title":"Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice","volume":"108","author":"Tsujii","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"Lakics","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/72247","article-title":"Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism","volume":"6","author":"Steinhoff","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0145","first-page":"197","article-title":"Phosphodiesterase 4 and its inhibitors in inflammatory diseases","volume":"35","author":"Jin","year":"2012","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0150","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0155","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0160","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaci.2010.08.014","article-title":"Phosphodiesterase 4B is essential for TH2-cell function and development of airway hyperresponsiveness in allergic asthma","volume":"126","author":"Jin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jdermsci.2014.10.005_bib0170","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nri1500","article-title":"The immunogenetics of asthma and eczema: a new focus on the epithelium","volume":"4","author":"Cookson","year":"2004","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181114002497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181114002497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T13:01:35Z","timestamp":1565960495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181114002497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0923181114002497"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.10.005","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}